•
Apr 05, 2020

Revvity Q1 2020 Earnings Report

PerkinElmer's first quarter results were announced, revealing a slight increase in revenue but a decrease in earnings per share compared to the previous year, and the company withdrew its full-year guidance due to COVID-19 uncertainties.

Key Takeaways

PerkinElmer reported a slight increase in revenue to $652.4 million, a 1% increase compared to the first quarter of 2019. However, GAAP EPS decreased to $0.30 from $0.32, and adjusted EPS decreased to $0.67 from $0.69. The company withdrew its full-year 2020 financial guidance due to uncertainties related to the COVID-19 pandemic.

Revenue increased by 1% to $652.4 million, but organic revenue decreased by 1%.

GAAP EPS from continuing operations decreased to $0.30, compared to $0.32 in Q1 2019.

Adjusted EPS decreased to $0.67, compared to $0.69 in Q1 2019.

Full-year 2020 financial guidance was withdrawn due to COVID-19 uncertainties.

Total Revenue
$652M
Previous year: $649M
+0.6%
EPS
$0.67
Previous year: $0.69
-2.9%
Organic Revenue Growth
-1%
Gross Profit
$308M
Previous year: $308M
+0.1%
Cash and Equivalents
$195M
Previous year: $134M
+45.4%
Free Cash Flow
$39.6M
Previous year: -$25.2M
-257.0%
Total Assets
$6.38B
Previous year: $6.09B
+4.9%

Revvity

Revvity

Revvity Revenue by Segment

Forward Guidance

For the second quarter of 2020, the Company forecasts GAAP revenue in the range of $610-720 million, GAAP earnings per share from continuing operations of at least $0.33 and, on a non-GAAP basis, adjusted earnings per share of at least $0.65.